Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Acasti Pharma
ACST
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.78
0.06
2.21%
At Close: -
$2.90
0.12
4.32%
After Hours: 8:39 AM EDT
15 minutes delayed
Get Report
Comment
Acasti Pharma (ACST) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Acasti Pharma (NASDAQ:ACST) Stock
Acasti Pharma Stock (NASDAQ: ACST)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, August 09, 2024
Acasti Pharma Q1 2025 EPS $(0.24) vs $(0.54) ...
Benzinga Newsdesk
Thursday, June 27, 2024
Acasti Reaches 50% Enrollment In Pivotal Phas...
Benzinga Newsdesk
Friday, June 21, 2024
Acasti Pharma FY24 Revenue $(1.35) Up From $(...
Benzinga Newsdesk
Monday, February 12, 2024
Acasti Pharma Q3 EPS $(0.21) Up From $(0.52) YoY
Happy Mohamed
Wednesday, February 07, 2024
Craig-Hallum Initiates Coverage On Acasti Pha...
Benzinga Newsdesk
Thursday, February 01, 2024
Acasti Announces Poster Detailing GTX-104 STR...
Benzinga Newsdesk
Thursday, January 18, 2024
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Monday, October 23, 2023
Acasti Announces Dosing Of First Patient In G...
Benzinga Newsdesk
Friday, October 06, 2023
Acasti Pharma Inc Files For Shelf Of Up To 6....
Benzinga Newsdesk
Thursday, September 28, 2023
Acasti Pharma 10% Owner Vimal Kavuru Reporte...
Charles Gross
Tuesday, September 26, 2023
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Why Acasti Pharma (ACST) Stock Is Exploding Higher
Henry Khederian
Acasti Pharma shares are trading higher after...
Benzinga Newsdesk
Acasti Announces $7.5M Private Placement Equi...
Bill Haddad
Wednesday, August 09, 2023
Acasti To Present GTX-104 Pharmacokinetic Com...
Benzinga Newsdesk
Monday, July 10, 2023
Acasti Announces WuXi Clinical As CRO To Cond...
Benzinga Newsdesk
Friday, July 07, 2023
Acasti Pharma Announces 1-For-6 Reverse Stock Split
Happy Mohamed
Wednesday, July 05, 2023
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Acasti Announces Alignment With FDA On GTX-10...
Benzinga Newsdesk
Friday, June 23, 2023
UPDATE: Acasti Pharma Q4 Adj EPS $(0.11), Inl...
Benzinga Newsdesk
Recap: Acasti Pharma Q4 Earnings
Benzinga Insights
Acasti Pharma Q4 Adj EPS $(0.11), Inline, Cas...
Benzinga Newsdesk
Tuesday, April 04, 2023
FDA Has Allowed Acasti Pharma To Proceed With...
Benzinga Newsdesk
Wednesday, February 15, 2023
EF Hutton Reiterates Buy on Acasti Pharma, Ma...
Benzinga Newsdesk
Tuesday, February 14, 2023
Acasti Pharma Q3 EPS $(0.09) Beats $(0.11) Es...
Benzinga Newsdesk
Earnings Scheduled For February 14, 2023
Benzinga Insights
Monday, February 13, 2023
Acasti Pharma's Earnings Outlook
Benzinga Insights
Wednesday, January 25, 2023
Acasti Receives Extension To Regain Complianc...
Benzinga Newsdesk
Tuesday, January 17, 2023
Acasti Pharma Discusses Clinical Study Result...
Benzinga Newsdesk
Friday, January 06, 2023
Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Thursday, January 05, 2023
Acasti To Host Conference Call On Tuesday, Ja...
Benzinga Newsdesk
Wednesday, December 28, 2022
Acasti Pharma shares are trading higher after...
Benzinga Newsdesk
Acasti Announces Preliminary Topline Results ...
Bill Haddad
Friday, December 23, 2022
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket
Lisa Levin
Thursday, December 22, 2022
Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures In Single Dose Pharmacokinetic Study For GTX-101
Bill Haddad
Tuesday, December 20, 2022
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Monday, December 19, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Benzinga Insights
EF Hutton Initiates Coverage On Acasti Pharma...
Benzinga Newsdesk
Thursday, December 15, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
Benzinga Insights
HC Wainwright & Co. Initiates Coverage On Aca...
Benzinga Newsdesk
Friday, December 09, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, December 07, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Monday, November 14, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Acasti Pharma Q2 EPS $(0.11) Down From $0.03 ...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2022
Benzinga Insights
Friday, November 11, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, November 10, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Monday, October 17, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, October 14, 2022
121 Stocks That Hit Their 52-Week Low
Benzinga Insights
Show More
